Multicenter Study of Risk-Adapted Therapy With Dose-Adjusted EPOCH-R in Adults With Untreated Burkitt Lymphoma

Overview of attention for article published in Journal of Clinical Oncology, May 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 12 news outlets
blogs: 1 blog

twitter: 57 X users
guideline: 4 clinical guideline sources

Readers on

mendeley: 134 Mendeley

So far, Altmetric has seen 24 news stories from 12 outlets.

Current Treatment of Burkitt Lymphoma and High-Grade B-Cell Lymphomas

Cancer Network, 18 Aug 2022

P. Connor Johnson, MD, and Jeremy S. Abramson MD, MMSc, discuss available treatments for patients with Burkitt lymphoma and high…

Brustkrebs-Screening auch für 70+? Rezepte gegen Krebs vom Meisterkoch

Medscape, 15 Sep 2020

Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.

Neue Option beim Cholangiokarzinom und 5-Jahres-Erfolge beim Melanom

Medscape, 08 Sep 2020

Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.

Neue tumoragnostische und Prostata-Ca-Therapien; wem nutzt Gensequenzierung?

Medscape, 01 Sep 2020

Es tut sich so viel in der Onkologie – und dies bei steigenden Patientenzahlen.

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 20 additional news stories.